Delivery of cells into the spinal canal for neurological targets.
Injecting cells directly into the cerebrospinal fluid surrounding the brain and spinal cord—bypassing the blood-brain barrier and placing cells near neurological tissue. It's invasive (requiring a lumbar puncture) but targets the right compartment for spinal and neurodegenerative conditions. Risks include infection, headache, and nerve injury, though serious complications are rare with skilled practitioners. Clinics offering intrathecal delivery for neurological conditions are signalling commitment to appropriate targeting, but ask about their infection-prevention protocols and whether they monitor CSF parameters before and after to confirm cells distributed evenly.
Médecine régénérative certifiée GMP au cœur de l'UE — à partir de 3 000–8 000 €, une fraction des prix américains ou allemands. Protocoles personnalisés pour patients de plus de 50 pays.
Évaluation médicale gratuite